CI Stock Overview
Cigna Corporation provides insurance and related products and services in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$268.03|
|52 Week High||US$273.58|
|52 Week Low||US$191.74|
|1 Month Change||1.75%|
|3 Month Change||8.85%|
|1 Year Change||12.60%|
|3 Year Change||63.99%|
|5 Year Change||58.03%|
|Change since IPO||3,903.77%|
Recent News & Updates
Cigna: A Forgotten Gem
Cigna does not get as much attention as other large healthcare companies but is growing at a rapid pace. The rising price of healthcare, increasing number of consumers with health insurance, and steady population growth will cause higher demand for the company's services. Management is making key decisions to increase shareholder value and improve the company, such as diversifying revenue, buying back shares, and offering a leading dividend.
Cigna: A Giant In The Industry Is A 'Buy'
In this article, we'll take a look at healthcare company Cigna. The company is a giant in the field of healthcare insurance. With almost 74,000 employees and revenues over $174 billion, this business is one of the largest on earth in terms of healthcare insurance and other services. This is my foundational thesis on Cigna Corporation - and my initial stance is a "BUY".
Here's Why Cigna (NYSE:CI) Has A Meaningful Debt Burden
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
|CI||US Healthcare||US Market|
Return vs Industry: CI exceeded the US Healthcare industry which returned 4.4% over the past year.
Return vs Market: CI exceeded the US Market which returned -21.2% over the past year.
|CI Average Weekly Movement||4.3%|
|Healthcare Industry Average Movement||9.7%|
|Market Average Movement||8.1%|
|10% most volatile stocks in US Market||16.8%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: CI is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: CI's weekly volatility (4%) has been stable over the past year.
About the Company
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations.
Cigna Fundamentals Summary
|CI fundamental statistics|
Is CI overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CI income statement (TTM)|
|Cost of Revenue||US$153.96b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
Aug 04, 2022
|Earnings per share (EPS)||16.98|
|Net Profit Margin||3.04%|
How did CI perform over the long term?See historical performance and comparison
1.7%Current Dividend Yield
Is CI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CI?
Other financial metrics that can be useful for relative valuation.
|What is CI's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does CI's PE Ratio compare to its peers?
|CI PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
CVS CVS Health
LH Laboratory Corporation of America Holdings
DGX Quest Diagnostics
RCM R1 RCM
Price-To-Earnings vs Peers: CI is good value based on its Price-To-Earnings Ratio (15.8x) compared to the peer average (31.3x).
Price to Earnings Ratio vs Industry
How does CI's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Earnings vs Industry: CI is good value based on its Price-To-Earnings Ratio (15.8x) compared to the US Healthcare industry average (18.8x)
Price to Earnings Ratio vs Fair Ratio
What is CI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||15.8x|
|Fair PE Ratio||35.2x|
Price-To-Earnings vs Fair Ratio: CI is good value based on its Price-To-Earnings Ratio (15.8x) compared to the estimated Fair Price-To-Earnings Ratio (35.2x).
Share Price vs Fair Value
What is the Fair Price of CI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CI ($268.03) is trading below our estimate of fair value ($747.16)
Significantly Below Fair Value: CI is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: CI is poor value based on its PEG Ratio (1.9x)
Discover undervalued companies
How is Cigna forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CI's forecast earnings growth (8.4% per year) is above the savings rate (1.9%).
Earnings vs Market: CI's earnings (8.4% per year) are forecast to grow slower than the US market (13.6% per year).
High Growth Earnings: CI's earnings are forecast to grow, but not significantly.
Revenue vs Market: CI's revenue (5.3% per year) is forecast to grow slower than the US market (8.2% per year).
High Growth Revenue: CI's revenue (5.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CI's Return on Equity is forecast to be low in 3 years time (16.4%).
Discover growth companies
How has Cigna performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CI has high quality earnings.
Growing Profit Margin: CI's current net profit margins (3%) are lower than last year (5.2%).
Past Earnings Growth Analysis
Earnings Trend: CI's earnings have grown significantly by 27.5% per year over the past 5 years.
Accelerating Growth: CI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CI had negative earnings growth (-36.2%) over the past year, making it difficult to compare to the Healthcare industry average (10.1%).
Return on Equity
High ROE: CI's Return on Equity (11.8%) is considered low.
Discover strong past performing companies
How is Cigna's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: CI's short term assets ($35.4B) do not cover its short term liabilities ($43.7B).
Long Term Liabilities: CI's short term assets ($35.4B) do not cover its long term liabilities ($62.8B).
Debt to Equity History and Analysis
Debt Level: CI's net debt to equity ratio (60.6%) is considered high.
Reducing Debt: CI's debt to equity ratio has increased from 33.2% to 71.7% over the past 5 years.
Debt Coverage: CI's debt is well covered by operating cash flow (24.5%).
Interest Coverage: CI's interest payments on its debt are well covered by EBIT (6.4x coverage).
Discover healthy companies
What is Cigna current dividend yield, its reliability and sustainability?
Dividend Score 5/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: CI's dividend (1.67%) is higher than the bottom 25% of dividend payers in the US market (1.6%).
High Dividend: CI's dividend (1.67%) is low compared to the top 25% of dividend payers in the US market (4.25%).
Stability and Growth of Payments
Stable Dividend: CI's dividends per share have been stable in the past 10 years.
Growing Dividend: CI's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (25.3%), CI's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (20.5%), CI's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
David Cordani (57 yo)
Mr. David Michael Cordani serves as Chair of the Board at Cigna Corporation since January 01, 2022. He has been the Chief Executive Officer and President of Cigna Corporation since December 25, 2009 and Ju...
CEO Compensation Analysis
Compensation vs Market: David's total compensation ($USD19.87M) is above average for companies of similar size in the US market ($USD13.43M).
Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.
Experienced Management: CI's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Experienced Board: CI's board of directors are considered experienced (3.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cigna Corporation's employee growth, exchange listings and data sources
- Name: Cigna Corporation
- Ticker: CI
- Exchange: NYSE
- Founded: 1792
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$85.039b
- Shares outstanding: 317.27m
- Website: https://www.cigna.com
Number of Employees
- Cigna Corporation
- 900 Cottage Grove Road
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/07/03 00:00|
|End of Day Share Price||2022/07/01 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.